… Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute respiratory
syndrome coronavirus… are major components of COVID-19 pathogenesis. The former …

… Although a limited proportion of all patients with COVID-19 … from immunotherapy that can
be used for treating COVID-19 … Cellular immunotherapy may be used in treating COVID-19 …

… of COVID-19. In addition to this, we also highlight various therapeutic options already in use
… of COVID-19 along with the potential immunotherapeutic interventions that can be targeted …

… as a potentially promising option for COVID-19-related acute … observed in patients with
COVID-19 experiencing ARDS are … Tcell engagers, the cancer immunotherapy community’s …

… and therapeutic interventions to combat the COVID-19 global healthcare crisis. The current
therapeutic options against the COVID-19 include repurposed drugs aimed at targets other …

… patients with COVID-19 and to control the spread of the causative agent, severe respiratory
syndrome coronavirus 2. … newly emerged diseases such as COVID-19, as these drugs have …

… COVID-19 immunotherapy. Several publications have mentioned a potential role of NK cells
in fighting various viral infections, as well as COVID-19 … in recovering patients [41], [42], [43], […

… Furthermore, advanced therapies are projected as potential treatment alternatives for
managing Chronic Post-COVID-19 syndromeand addressing its associated long-term …

… for both COVID-19 and cancer management in patients with both … treatment of patients with
cancer during the COVID-19 pandemic … option in patients with COVID-19–related pneumonia. …

… inform therapeutic decisions, for example, on selecting the most appropriate immunotherapeutic
agents and timing their administration, to reduce morbidity and mortality of COVID-19. …